Old Web
English
Sign In
Acemap
>
authorDetail
>
Tage Ramakrishna
Tage Ramakrishna
Medicine
Dermatology
Randomized controlled trial
Adverse effect
Psoriasis
4
Papers
198
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety and Efficacy of a Once-Daily Halobetasol Propionate 0.01% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Results of Two Phase 3 Randomized Controlled Trials.
2018
Journal of Drugs in Dermatology
Lawrence Green
Francisco A. Kerdel
Fran E. Cook-Bolden
Jerry Bagel
Tina Lin
Gina Martin
Radhakrishnan Pillai
Robert Israel
Tage Ramakrishna
Show All
Source
Cite
Save
Citations (3)
Safety and efficacy of a fixed combination of halobetasol and tazarotene in the treatment of moderate-to-severe plaque psoriasis: Results of 2 phase 3 randomized controlled trials
2018
Journal of The American Academy of Dermatology
Linda Stein Gold
Mark Lebwohl
Jeffrey L. Sugarman
David M. Pariser
Tina Lin
Gina Martin
Radhakrishnan Pillai
Robert J. Israel
Tage Ramakrishna
Show All
Source
Cite
Save
Citations (25)
Safety, Tolerability, and Pharmacokinetics of Therapeutic and Supratherapeutic Doses of Tramadol Hydrochloride in Healthy Adults: A Randomized, Double‐Blind, Placebo‐Controlled Multiple‐Ascending‐Dose Study
2017
Clinical pharmacology in drug development
Byron DeLemos
Henry Richards
Joris Vandenbossche
Jay Ariyawansa
Jaya Natarajan
Binu Alexander
Tage Ramakrishna
Thomas Murtaugh
Hans‐Jürgen Stahlberg
Show All
Source
Cite
Save
Citations (6)
Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies
2013
Journal of The American Academy of Dermatology
Boni E. Elewski
Phoebe Rich
Richard Pollak
David M. Pariser
Shinichi Watanabe
Hisato Senda
Chikara Ieda
Kathleen J. Smith
Radhakrishnan Pillai
Tage Ramakrishna
Olin Jt
Show All
Source
Cite
Save
Citations (164)
1